Targeting RAS signalling pathways in cancer therapy
作者： Julian Downward
DOI: 10.1038/NRC969
关键词: Signalling 、 Gene 、 Signalling pathways 、 Biology 、 Normal cell 、 Cancer therapy 、 Ras Inhibitor 、 Cell biology 、 Anti-apoptotic Ras signalling cascade 、 Malignant transformation
摘要: … other ways to activate the same pathways. The RAS signalling pathways are now understood in great detail … This work showed great promise for FTIs in the treatment of human cancers. …
nature.com
readcube.com 
researchgate.net 参考文章(87)
R. Marais, Y. Light, H.F. Paterson, C.J. Marshall, Ras recruits Raf‐1 to the plasma membrane for activation by tyrosine phosphorylation. The EMBO Journal. ,vol. 14, pp. 3136- 3145 ,(1995) , 10.1002/J.1460-2075.1995.TB07316.X
Judith S. Sebolt-Leopold, David T. Dudley, Roman Herrera, Keri Van Becelaere, Amy Wiland, Richard C. Gowan, Haile Tecle, Stephen D. Barrett, Alexander Bridges, Sally Przybranowski, W.R. Leopold, Alan R. Saltiel, Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nature Medicine. ,vol. 5, pp. 810- 816 ,(1999) , 10.1038/10533
George C. Prendergast, Actin' up: RhoB in cancer and apoptosis Nature Reviews Cancer. ,vol. 1, pp. 162- 168 ,(2001) , 10.1038/35101096
Caroline J. Fuery, Tanya L. Applegate, Walter Wouters, Gerard Sanz, Marc Venet, Ann Devine, Stacy Skrzat, Gerda Smets, David W. End, Charles Bowden, Patrick Angibaud, Alison V. Todd, Herve Poignet, Characterization of the Antitumor Effects of the Selective Farnesyl Protein Transferase Inhibitor R115777 in Vivo and in Vitro Cancer Research. ,vol. 61, pp. 131- 137 ,(2001)
A. Wittinghofer, Signal transduction via Ras Biological Chemistry. ,vol. 379, pp. 933- 937 ,(1998)
Pablo Rodriguez-Viciana, Patricia H. Warne, Ritu Dhand, Bart Vanhaesebroeck, Ivan Gout, Michael J. Fry, Michael D. Waterfield, Julian Downward, PHOSPHATIDYLINOSITOL-3-OH KINASE AS A DIRECT TARGET OF RAS Nature. ,vol. 370, pp. 527- 532 ,(1994) , 10.1038/370527A0
David C. Heimbrook, Elaine Rands, Michelle S. Ellis-Hutchings, Hema G. Bhimnathwala, Allen I. Oliff, Charles A. Omer, Nancy E. Kohl, Samuel L. Graham, Samuel V. Machotka, Carolyn A. Buser, Robert B. Lobell, Astrid M. Kral, Theresa M. Williams, Dongming Liu, S. Jane deSolms, Mary Jo Brucker, Joseph P. Davide, Marc T. Abrams, William C. Lumma, Christopher J. Dinsmore, George D. Hartman, Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. Cancer Research. ,vol. 61, pp. 8758- 8768 ,(2001)
G. G. Kelley, Phospholipase Cepsilon: a novel Ras effector The EMBO Journal. ,vol. 20, pp. 743- 754 ,(2001) , 10.1093/EMBOJ/20.4.743
Maria Sibilia, Alexander Fleischmann, Axel Behrens, Laura Stingl, Joseph Carroll, Fiona M. Watt, Joseph Schlessinger, Erwin F. Wagner, The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development Cell. ,vol. 102, pp. 211- 220 ,(2000) , 10.1016/S0092-8674(00)00026-X
Nancy E. Kohl, Charles A. Omer, Michael W. Conner, Neville J. Anthony, Joseph P. Davide, S. Jane Desolms, Elizabeth A. Giuliani, Robert P. Gomez, Samuel L. Graham, Kelly Hamilton, Laurence K. Handt, George D. Hartman, Kenneth S. Koblan, Astrid M. Kral, Patricia J. Miller, Scott D. Mosser, Timothy J. O'Neill, Elaine Rands, Michael D. Schaber, Jackson B. Gibbs, Allen Oliff, Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice Nature Medicine. ,vol. 1, pp. 792- 797 ,(1995) , 10.1038/NM0895-792